Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1874 1
1893 1
1903 1
1911 1
1914 1
1919 1
1924 1
1927 1
1930 1
1944 2
1946 1
1947 1
1951 3
1952 1
1953 1
1954 1
1956 2
1957 1
1958 4
1959 2
1960 2
1961 2
1962 2
1963 3
1964 7
1965 6
1966 12
1967 8
1968 8
1969 19
1970 16
1971 27
1972 41
1973 41
1974 60
1975 193
1976 274
1977 221
1978 231
1979 235
1980 288
1981 354
1982 345
1983 424
1984 562
1985 598
1986 645
1987 714
1988 791
1989 894
1990 1047
1991 1047
1992 1097
1993 1196
1994 1156
1995 1193
1996 1321
1997 1303
1998 1324
1999 1359
2000 1422
2001 1328
2002 1319
2003 1379
2004 1503
2005 1478
2006 1463
2007 1514
2008 1535
2009 1560
2010 1584
2011 1604
2012 1671
2013 1772
2014 2021
2015 2164
2016 2170
2017 2270
2018 2500
2019 2771
2020 3174
2021 3686
2022 3675
2023 3473
2024 1777

Text availability

Article attribute

Article type

Publication date

Search Results

64,371 results

Results by year

Filters applied: . Clear all
The following terms were not found in PubMed: Fadakare, sogheh
Page 1
Growth Hormone and Aging.
Hage C, Salvatori R. Hage C, et al. Endocrinol Metab Clin North Am. 2023 Jun;52(2):245-257. doi: 10.1016/j.ecl.2022.10.003. Epub 2022 Nov 16. Endocrinol Metab Clin North Am. 2023. PMID: 36948778 Review.
Growth hormone (GH) secretion declines with aging (somatopause). One of the most controversial issues in aging is GH treatment of older adults without evidence of pituitary pathology. ...Although most animal studies reported an association between decreased GH …
Growth hormone (GH) secretion declines with aging (somatopause). One of the most controversial issues in aging is GH treatment …
Musculoskeletal Effects of Altered GH Action.
Young JA, Zhu S, List EO, Duran-Ortiz S, Slama Y, Berryman DE. Young JA, et al. Front Physiol. 2022 May 19;13:867921. doi: 10.3389/fphys.2022.867921. eCollection 2022. Front Physiol. 2022. PMID: 35665221 Free PMC article. Review.
In addition to its metabolic and musculoskeletal effects, GH is closely associated with aging, with levels declining as individuals age but GH action negatively correlating with lifespan. GH's effects have been studied in human conditions of GH alterat …
In addition to its metabolic and musculoskeletal effects, GH is closely associated with aging, with levels declining as individuals a …
Long-acting growth hormone in 2022.
Steiner M, Frank J, Saenger P. Steiner M, et al. Pediatr Investig. 2023 Jan 3;7(1):36-42. doi: 10.1002/ped4.12358. eCollection 2023 Mar. Pediatr Investig. 2023. PMID: 36967745 Free PMC article. Review.
After the isolation of pituitary growth hormone (GH) in 1957, this form of GH, always in limited supply, was the only drug available for the treatment of GH deficiency. ...Now in 2021 long-acting GH (LAGH) became available the world over making GH …
After the isolation of pituitary growth hormone (GH) in 1957, this form of GH, always in limited supply, was the only drug ava …
Genetic disorders of GH action pathway.
Domené HM, Fierro-Carrión G. Domené HM, et al. Growth Horm IGF Res. 2018 Feb;38:19-23. doi: 10.1016/j.ghir.2017.12.004. Epub 2017 Dec 12. Growth Horm IGF Res. 2018. PMID: 29249625 Review.
While insensitivity to GH (GHI) is characterized by low IGF-I levels, normal or elevated GH levels, and lack of IGF-I response to GH treatment, IGF-I resistance is characterized by elevated IGF-I levels with normal/high GH levels. ...Complete GH …
While insensitivity to GH (GHI) is characterized by low IGF-I levels, normal or elevated GH levels, and lack of IGF-I response …
Growth hormone isoforms.
Baumann GP. Baumann GP. Growth Horm IGF Res. 2009 Aug;19(4):333-40. doi: 10.1016/j.ghir.2009.04.011. Epub 2009 May 24. Growth Horm IGF Res. 2009. PMID: 19467614 Review.
The GH-N gene is expressed in the pituitary, the GH-V gene in the placenta. ...GH isoforms cross-react in most immunoassays, but assays specific for 22K-GH, 20K-GH and GH-V have been developed. ...
The GH-N gene is expressed in the pituitary, the GH-V gene in the placenta. ...GH isoforms cross-react in most immunoas …
Extrapituitary growth hormone and growth?
Harvey S, Baudet ML. Harvey S, et al. Gen Comp Endocrinol. 2014 Sep 1;205:55-61. doi: 10.1016/j.ygcen.2014.03.041. Epub 2014 Apr 16. Gen Comp Endocrinol. 2014. PMID: 24746676 Review.
While growth hormone (GH) is obligatory for postnatal growth, it is not required for a number of growth-without-GH syndromes, such as early embryonic or fetal growth. ...Moreover, as the expression of the GH receptor (GHR) gene mirrors that of GH in ex …
While growth hormone (GH) is obligatory for postnatal growth, it is not required for a number of growth-without-GH syndromes, …
Growth hormone and nonalcoholic fatty liver disease.
Ma IL, Stanley TL. Ma IL, et al. Immunometabolism (Cobham). 2023 Jul 27;5(3):e00030. doi: 10.1097/IN9.0000000000000030. eCollection 2023 Jul. Immunometabolism (Cobham). 2023. PMID: 37520312 Free PMC article. Review.
In humans, individuals with GH deficiency and GH resistance demonstrate an increased prevalence of NAFLD compared to controls, with improvement in hepatic lipid, steatohepatitis, and fibrosis following GH replacement. As a corollary, individuals with GH …
In humans, individuals with GH deficiency and GH resistance demonstrate an increased prevalence of NAFLD compared to controls, …
Novel long-acting GH preparations.
Doknic M, Stojanovic M, Popovic V. Doknic M, et al. Pediatr Endocrinol Rev. 2014 Dec;12(2):206-12. Pediatr Endocrinol Rev. 2014. PMID: 25581986 Review.
Currently a variety of modified GH molecules which delay GH clearance (CTP modified GH, recombinant polypeptide XTEN, GH conjugated with albumin, GH linked to immunoglobulin) are studied and the ongoing studies are in different phases (from I-II …
Currently a variety of modified GH molecules which delay GH clearance (CTP modified GH, recombinant polypeptide XTEN, …
Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis.
Locatelli V, Bianchi VE. Locatelli V, et al. Int J Endocrinol. 2014;2014:235060. doi: 10.1155/2014/235060. Epub 2014 Jul 23. Int J Endocrinol. 2014. PMID: 25147565 Free PMC article. Review.
Eighteen clinical studies considered the effect with GH treatment, fourteen studies reported the clinical effects with IGF-1 administration, and seven related to the GH/IGF-1 effect on bone healing. ...GH interacts with sex steroids in the anabolic process. …
Eighteen clinical studies considered the effect with GH treatment, fourteen studies reported the clinical effects with IGF-1 administ …
Growth hormone: isoforms, clinical aspects and assays interference.
Ribeiro de Oliveira Longo Schweizer J, Ribeiro-Oliveira A Jr, Bidlingmaier M. Ribeiro de Oliveira Longo Schweizer J, et al. Clin Diabetes Endocrinol. 2018 Aug 28;4:18. doi: 10.1186/s40842-018-0068-1. eCollection 2018. Clin Diabetes Endocrinol. 2018. PMID: 30181896 Free PMC article. Review.
The measurement of circulating concentrations of growth hormone (GH) is an indispensable tool in the diagnosis of both GH deficiency and GH excess. ...The 22KD GH (22 K-GH) is the main isoform in circulation, followed by 20KD GH (20 K- …
The measurement of circulating concentrations of growth hormone (GH) is an indispensable tool in the diagnosis of both GH defi …
64,371 results
You have reached the last available page of results. Please see the User Guide for more information.